Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × HMPL-013 × Clear all

NCT05168527 2022-01-14

The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms